Literature DB >> 8161784

Platelet coagulation factor Va: the major secretory platelet phosphoprotein.

M D Rand1, M Kalafatis, K G Mann.   

Abstract

Platelet-derived coagulation factor Va is the primary secreted substrate for a thrombin-stimulation-dependent platelet kinase. Human platelet factor Va, consisting of a molecular weight (M(r)) 105,000 heavy chain and an M(r) 74,000 light chain, incorporates phosphate in at least two sites on the light chain. Phosphorylated factor Va represents 50% of the secreted protein-associated phosphate. This modification occurs exclusively at serine residues and is inhibited by H-7 and staurosporine, which suggests a protein kinase C (PKC)-mediated event. Purified plasma factor V and Va are phosphorylated in the light chain region by rat brain PKC. The activity of platelet factor Va in prothrombinase on platelets is not altered when phosphorylation is inhibited by staurosporine. Plasma-derived factor Va in the presence of thrombin stimulated platelets is phosphorylated on both the heavy chain and the light chain. Plasma factor V and factor Va heavy chain phosphorylation occurs without light chain phosphorylation in the presence of added 32P gamma-ATP and non-stimulated or collagen-stimulated platelets or casein kinase II. This differential phosphorylation of factor Va heavy and light chain shows two independent platelet kinase activities that act on factor Va. The heavy chain factor V/Va kinase activity is similar to casein kinase II, which we have demonstrated previously to act on factor Va and accelerate activated protein C inactivation of the cofactor. Our data show platelet-dependent phosphorylation of platelet and plasma factor V and Va resulting in significant covalent modifications of the cofactor. These modifications may play a role in directing the extracellular distribution of factor V and factor Va.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8161784

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  The Prothrombinase Complex: Assembly and Function.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Platelet protein S directly inhibits procoagulant activity on platelets and microparticles.

Authors:  Fabian Stavenuiter; Nicole F Davis; Erning Duan; Andrew J Gale; Mary J Heeb
Journal:  Thromb Haemost       Date:  2012-12-13       Impact factor: 5.249

3.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

4.  The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.

Authors:  J O Egan; M Kalafatis; K G Mann
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

Review 5.  Ecto-protein kinase CK2, the neglected form of CK2.

Authors:  Mathias Montenarh; Claudia Götz
Journal:  Biomed Rep       Date:  2018-02-21

6.  Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity.

Authors:  Jeremy P Wood; Jay R Silveira; Nicole M Maille; Laura M Haynes; Paula B Tracy
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

7.  Mass spectrometry based analysis of human plasma-derived factor X revealed novel post-translational modifications.

Authors:  Guillaume Chevreux; Nolwenn Tilly; Valegh Faid; Nicolas Bihoreau
Journal:  Protein Sci       Date:  2015-09-18       Impact factor: 6.725

8.  Biological Insights into Therapeutic Protein Modifications throughout Trafficking and Their Biopharmaceutical Applications.

Authors:  Xiaotian Zhong; Jill F Wright
Journal:  Int J Cell Biol       Date:  2013-04-18

Review 9.  The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.

Authors:  Oskar Eriksson; Camilla Mohlin; Bo Nilsson; Kristina N Ekdahl
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

10.  LC-MS/MS analysis of the dog serum phosphoproteome reveals novel and conserved phosphorylation sites: Phosphoprotein patterns in babesiosis caused by Babesia canis, a case study.

Authors:  Asier Galán; Anita Horvatić; Josipa Kuleš; Petra Bilić; Jelena Gotić; Vladimir Mrljak
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.